NLRP3 and metabolic disease: The aortic downregulation of NLRP3, which has emerged as an important regulator of inflammation in metabolic disorders and atherosclerosis [6, 7] and is recognized for its capacity to induce collagen production in fibroblasts [12], supports the link between the decrease in vascular inflammation and fibrosis after apo A-I gene transfer.